0
     

Report Added
Report already added
Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report

Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report

Summary

Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Shionogi & Co., Ltd. (Shionogi or 'the group') produces and sells pharmaceutical products. It is involved in the research, development, manufacture, and marketing of ethical drugs, over-the-counter (OTC) drugs and diagnostic products. It caters to the healthcare needs and addresses the social issues of society. The company offers its products under various brands such as AIMIX, IRTRA, Crestor, Irbetan, Cymbalta, Pirespa, Differin, Rapiacta, Finibax, OxyContin, OxiNorm, OxiFast, Sedes, Correct Series, opon Series, Brightpoc Flu. Shionogi has 51 subsidiaries and three affiliates. It operates in Japan, Europe, North America and other regions of the world. The company is headquartered in Osaka, Japan.

Scope

- Detailed information on Shionogi & Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Shionogi & Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Shionogi & Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Shionogi & Co., Ltd.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Shionogi & Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Shionogi & Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Shionogi & Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Shionogi & Co., Ltd.'s business structure, strategy and prospects.

Table of Contents

Company Snapshot
Shionogi & Co., Ltd.: Company Overview
Shionogi & Co., Ltd.: Overview and Key Facts
Shionogi & Co., Ltd.: Overview
Shionogi & Co., Ltd.: Key Facts
Shionogi & Co., Ltd.: Key Employees
Shionogi & Co., Ltd.: Key Employee Biographies
Shionogi & Co., Ltd.: Major Products and Services
Shionogi & Co., Ltd.: Company History
Shionogi & Co., Ltd.: Management Statement
Shionogi & Co., Ltd.: Locations and Subsidiaries
Shionogi & Co., Ltd.: Key Competitors
Shionogi & Co., Ltd.: Company Analysis
Shionogi & Co., Ltd.: Business Description
Shionogi & Co., Ltd.: SWOT Analysis
Shionogi & Co., Ltd.: SWOT Overview
Shionogi & Co., Ltd.: Strengths
Shionogi & Co., Ltd.: Weaknesses
Shionogi & Co., Ltd.: Opportunities
Shionogi & Co., Ltd.: Threats
Shionogi & Co., Ltd.: Corporate Financial Deals Activity
Shionogi & Co., Ltd.: Financial Deals Overview
Shionogi & Co., Ltd.: Targets and Partners
Shionogi & Co., Ltd.: Top Deals 2019 - 2023YTD*
Shionogi & Co., Ltd.: Advisors
Shionogi & Co., Ltd.: Top Legal Advisors
Shionogi & Co., Ltd.: Mergers and Acquisitions
Shionogi & Co., Ltd.: Corporate Venturing
Shionogi & Co., Ltd.: Partnership
Shionogi & Co., Ltd.: Recent Developments
Shionogi & Co., Ltd.: News and Events Summary
Shionogi & Co., Ltd.: Corporate Governance
Shionogi & Co., Ltd.: Financial Deals
Shionogi & Co., Ltd.: Financial Performance
Shionogi & Co., Ltd.: Research & Development
Shionogi & Co., Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Shionogi & Co., Ltd.: Key Facts
Table 2: Shionogi & Co., Ltd.: Key Employees
Table 3: Shionogi & Co., Ltd.: Company History
Table 4: Shionogi & Co., Ltd.: Locations and Subsidiaries
Table 5: Shionogi & Co., Ltd.: Key Competitors
Table 6: Shionogi & Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Shionogi & Co., Ltd.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Shionogi & Co., Ltd.: M&A Average Deal Size - Value (US$m)
Table 9: Shionogi & Co., Ltd.: Targets and Partners
Table 10: Shionogi & Co., Ltd.: Top Deals 2019 - 2023YTD*
Table 11: Shionogi & Co., Ltd.: Legal Advisor Ranking by Value (US$m)
Table 12: Shionogi & Co., Ltd.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 13: Shionogi & Co., Ltd.: M&A Activity by Geography (2019 - YTD*2023)
Table 14: Shionogi & Co., Ltd.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 15: Shionogi & Co., Ltd.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 16: Shionogi & Co., Ltd.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 17: Shionogi & Co., Ltd.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 18: Shionogi & Co., Ltd.: News and Events Summary
Table 19: Shionogi & Co., Ltd.: Corporate Governance
Table 20: Shionogi & Co., Ltd.: Financial Deals
Table 21: Shionogi & Co., Ltd.: Financial Performance
Table 22: Shionogi & Co., Ltd.: Research & Development
Table 23: Shionogi & Co., Ltd.: Strategy and Operations

List of Figures
Figure 1: Shionogi & Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Shionogi & Co., Ltd.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 3: Shionogi & Co., Ltd.: M&A Average Deal Size - Value (US$m)
Figure 4: Shionogi & Co., Ltd.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 5: Shionogi & Co., Ltd.: M&A Activity by Geography (2019 - YTD*2023)
Figure 6: Shionogi & Co., Ltd.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 7: Shionogi & Co., Ltd.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 8: Shionogi & Co., Ltd.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 9: Shionogi & Co., Ltd.: Partnership Trend by Deal Type (2019 - YTD*2023)

Report Title: Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Bispecific Antibodies  Market & Clinical Pipeline Insight 2028

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline